Biomarker identification for Alzheimer’s disease through integration of comprehensive Mendelian randomization and proteomics data
Abstract Background Alzheimer’s disease (AD) is the main cause of dementia with few effective therapies. We aimed to identify potential plasma biomarkers or drug targets for AD by investigating the causal association between plasma proteins and AD by integrating comprehensive Mendelian randomization...
Saved in:
| Main Authors: | Hui Zhan, Davis Cammann, Jeffrey L. Cummings, Xianjun Dong, Jingchun Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Journal of Translational Medicine |
| Online Access: | https://doi.org/10.1186/s12967-025-06317-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of biomarkers for chronic lymphocytic leukemia risk: a proteome-wide Mendelian randomization study
by: Changyu Jin, et al.
Published: (2025-01-01) -
Unveiling Novel Protein Biomarkers for Psoriasis Through Integrated Analysis of Human Plasma Proteomics and Mendelian Randomization
by: Mao R, et al.
Published: (2024-12-01) -
Integrative Proteomics and Genomics Identify Novel Biomarkers and Therapeutic Targets in Vitiligo via Mendelian Randomization
by: Chenjue Yan, et al.
Published: (2025-06-01) -
Uncovering drug targets for cluster headache through proteome-wide Mendelian randomization analysis
by: Zhonghua Xiong, et al.
Published: (2025-03-01) -
Applying machine learning to high-dimensional proteomics datasets for the identification of Alzheimer’s disease biomarkers
by: Christoffer Ivarsson Orrelid, et al.
Published: (2025-03-01)